CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RBC Raises Price Target on Amgen to $430 From $400, Keeps Outperform Rating

Positive
AI Analysis

Summary

RBC Capital Markets raised its price target on Amgen to $430 from $400 while maintaining an Outperform rating on the stock.

Importance:2/10
Sentiment:
0.40
analyst_ratingprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on October 8, 2026 11:30 AM

Read Original